A clinical trial demonstrates that a drug that starves tumors extends mesothelioma patients' lives.

Published Date: 19 Apr 2023

Results from the ATOMIC-Meso clinical trial, which was conducted in collaboration with Polaris Pharmaceuticals, Inc., were presented by Peter Szlosarek, Professor of Medical Oncology at Queen Mary's Barts Cancer Institute. the American Association.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

4.

The pandemic had little impact on mental health symptoms.

5.

Men over 75 years old may be significantly more likely to commit suicide if they have cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot